Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ScarX Therapeutics

ScarX Therapeutics
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$2M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of innovative therapeutics intended to address excessive dermal scarring. The company's therapeutics are used to produce a small molecule therapeutic drug with anti-fibrotic activity that reduce dermal scarring during wound healing, enabling patients to have better post-surgical outcomes following cosmetic and reconstructive plastic surgeries.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Personal Products
Primary Office
  • 661 University Avenue
  • Suite 465
  • Toronto, Ontario M5G 1M1
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ScarX Therapeutics’s full profile, request a free trial.

ScarX Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 16-Feb-2016 $2M 00.00 Completed Clinical Trials - Phase 1
2. Grant 24-Jan-2013 000 00.00 Completed Pre-Clinical Trials
1. Early Stage VC 25-Sep-2012 $1.7M $1.7M Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

ScarX Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Business Development Bank of Canada Venture Capital Minority 000 0000 000000 0
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
Novotek Pharmaceuticals Corporation Minority 000 0000 000000 0
Ontario Centres of Excellence Not-For-Profit Venture Capital Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0

ScarX Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Stephen Whitehead President, Board Member & Chief Executive Officer
Benjamin Alman Chief Scientific Officer
Parimal Nathwani Executive Chairman

ScarX Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Cameron Groome Self Board Member 000 0000
Michael Lincoln Accel-Rx Board Member 000 0000
Michael Salter Ph.D Self Board Member 000 0000
Parimal Nathwani Self Executive Chairman 000 0000
Raphael Hofstein Ph.D Toronto Innovation Acceleration Partners Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »